SCHEMBL4248928

SCHEMBL4248928

CN(CC(N)=O)C1(C)CC1

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35
OPRM1 P35372 1/20 0.30
OPRL1 P41146 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24941933 0.76 TDP1 (0.38)
SCHEMBL22952479 0.74
SCHEMBL138662 0.66
SCHEMBL13407442 0.66 LMNA (0.37) DDB1CRBN
Hydrochloric Acid SCHEMBL3571581 0.64 LMNA (0.35) DDB1CRBN
SCHEMBL6753687 0.64
Hydrochloric Acid SCHEMBL2860597 0.64
SCHEMBL19080631 0.64
Hydrochloric Acid SCHEMBL891026 0.64
Bromide SCHEMBL5886352 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2077719-A2 PIPERIDINE AND PYRROLIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Merck and Co., Inc. (US) 2009-07-15 EP claimed
WO-2008036316-A2 PIPERIDINE AND PYRROLIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2008-03-27 WO claimed